Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
2.95
Oct 23 • 3:59 PM ET Dollar change+0.08 Percentage change(2.79%)
Aftermarket Close
2.95
Aftermarket • 4:15 PM ET Dollar change0.00 Percentage change(0.00%)
Index
-
Market Cap
48.56M
Enterprise Value
33.71M
Income
-15.48M
Sales
17.51M
Book/sh
2.24
Cash/sh
0.92
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
60
IPO
Jul 26, 2016
P/E
-
Forward P/E
-
PEG
-
P/S
2.77
P/B
1.32
P/C
3.20
P/FCF
-
EV/EBITDA
-
EV/Sales
1.93
Quick Ratio
4.30
Current Ratio
8.71
Debt/Eq
0.01
LT Debt/Eq
0.00
Option/Short
Yes / Yes
EPS (ttm)
-0.94
EPS next Y
-0.11
EPS next Q
-0.06
EPS this Y
-68.62%
EPS next Y
85.80%
EPS next 5Y
-
EPS past 3/5Y
- -2.60%
Sales past 3/5Y
-14.86% 23.47%
EPS Y/Y TTM
-1719.88%
Sales Y/Y TTM
-53.40%
EPS Q/Q
-737.01%
Sales Q/Q
-68.69%
Insider Own
18.67%
Insider Trans
5.95%
Inst Own
25.18%
Inst Trans
-4.31%
ROA
-30.94%
ROE
-34.83%
ROIC
-41.93%
Gross Margin
36.39%
Oper. Margin
-75.72%
Profit Margin
-88.45%
SMA20
1.47%
SMA50
-3.68%
SMA200
-17.76%
Trades
Shs Outstand
16.46M
Shs Float
13.39M
52W High
5.49 -46.27%
52W Low
2.66 10.90%
Volatility
5.27% 4.39%
ATR (14)
0.14
RSI (14)
51.32
Beta
1.18
Rel Volume
0.43
Avg Volume
28.91K
Volume
12,498
Perf Week
6.50%
Perf Month
1.37%
Perf Quarter
-2.32%
Perf Half Y
-25.13%
Perf YTD
-25.88%
Perf Year
-10.33%
Perf 3Y
29.39%
Perf 5Y
-26.80%
Perf 10Y
-53.54%
Prev Close
2.87
Price
2.95
Change %
2.79%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sachetta EricDirectorAug 28 '26Buy3.4437,537129,015267,480Aug 31 12:35 PM
Sachetta EricDirectorAug 31 '26Buy3.5427,30496,602294,784Aug 31 12:35 PM
Sachetta EricDirectorAug 27 '26Buy3.1810,92534,752229,943Aug 28 02:29 PM
Sachetta EricDirectorAug 26 '26Buy3.299,70831,930219,018Aug 28 02:29 PM
Sachetta EricDirectorAug 24 '26Buy3.2534,697112,904209,310Aug 25 09:26 AM
Sardano Joseph CCHIEF EXECUTIVE OFFICERAug 20 '26Buy3.0220,00060,4861,220,293Aug 24 04:00 PM
Sachetta EricDirectorAug 20 '26Buy3.1324,00075,072167,613Aug 24 03:08 PM
Sachetta EricDirectorAug 21 '26Buy3.257,00022,778174,613Aug 24 03:08 PM
Sachetta EricDirectorMay 12 '26Buy3.331,5005,002143,613May 12 01:53 PM
Sachetta EricDirectorFeb 24 '26Buy3.812,0007,620142,113Feb 26 09:25 AM
Sachetta EricDirectorNov 21 '25Buy3.937,00027,510140,113Nov 21 02:28 PM
Sachetta EricDirectorNov 13 '25Buy4.502,50011,250133,113Nov 20 02:03 PM
Sardano Joseph CCHIEF EXECUTIVE OFFICERNov 18 '25Buy4.0325,000100,7501,200,293Nov 19 09:34 AM
Sardano MichaelPRESIDENT AND GENERAL COUNSELNov 18 '25Buy3.801,0003,800118,839Nov 19 09:15 AM
Sardano MichaelPRESIDENT AND GENERAL COUNSELNov 11 '25Buy4.261,0004,260117,839Nov 12 09:53 AM
Sensus Healthcare, Inc. is a medical device company, which engages in the provision of treatment for both oncological and non-oncological skin conditions. The company was founded by Joseph C. Sardano, Richard Golin, Kalman Fishman, and Stephen Cohen on May 7, 2010 and is headquartered in Boca Raton, FL.
Co-FounderMr. Joseph C. Sardano
PresidentMr. Michael J. Sardano J.D.
Chief Financial OfficerMr. Javier Rampolla
Chief Operating OfficerMs. Magdalena Martinez
Chief Technology OfficerMr. Carlton Chow